Entero Healthcar Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
179.00
138.00
35.00
-3.00
-19.00
-10.00
Adjustment
107.00
44.00
86.00
71.00
41.00
42.00
Changes In working Capital
-136.00
-221.00
-145.00
-100.00
-46.00
-95.00
Cash Flow after changes in Working Capital
149.00
-38.00
-23.00
-32.00
-24.00
-64.00
Cash Flow from Operating Activities
96.00
-76.00
-36.00
-45.00
-35.00
-68.00
Cash Flow from Investing Activities
-302.00
232.00
-704.00
-48.00
-161.00
-30.00
Cash Flow from Financing Activities
123.00
-73.00
862.00
72.00
211.00
88.00
Net Cash Inflow / Outflow
-82.00
81.00
122.00
-21.00
14.00
-10.00
Opening Cash & Cash Equivalents
229.00
147.00
25.00
46.00
32.00
43.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
146.00
229.00
147.00
25.00
46.00
32.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Entero Healthcar
Figures in Cr
standaloned Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
30.19
143.12
-113.00
-78.91%
Adjustment
-79.83
67.49
-146.00
-218.28%
Changes In working Capital
-6.17
-214.43
208.00
97.12%
Cash Flow after changes in Working Capital
-55.82
-3.82
-52.00
-1361.26%
Cash Flow from Operating Activities
-59.72
-40.82
-19.00
-46.30%
Cash Flow from Investing Activities
-132.28
-44.66
-88.00
-196.19%
Cash Flow from Financing Activities
97.58
94.04
3.00
3.76%
Net Cash Inflow / Outflow
-94.42
8.56
-102.00
-1203.04%
Opening Cash & Cash Equivalents
151.18
17.55
134.00
761.42%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
56.76
26.11
30.00
117.39%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 225.15% vs -109.97% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
96.20
-76.87
225.15%






